West Pharmaceutical Services, Inc. (WST) Q4 2022 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET

Company Participants

Quintin Lai - VP, Strategy & IR

Eric Green - Chair, President & CEO

Bernard Birkett - SVP and Chief Financial & Operations Officer

Conference Call Participants

Lawrence Solow - CJS Securities

Matthew Larew - William Blair & Company

Jacob Johnson - Stephens Inc.

John Sourbeer - UBS

Derik De Bruin - Bank of America Merrill Lynch

Paul Knight - KeyBanc Capital Markets

David Windley - Jefferies

Justin Bowers - Deutsche Bank

Operator

Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions].

I would now like to hand the conference over to your speaker today, Quintin Lai, Vice President, Investor Relations. Please go ahead.

Quintin Lai

Thank you, Shannon. Good morning, and welcome to West's Fourth Quarter and Full Year 2022 Conference Call.

We issued our financial results this morning and the release has been posted in the Investors section on the company's website located at westpharma.com. This morning, Eric Green and Bernard Birkett will review our financial results, provide an update on our business and present an update on our financial outlook for the full year 2023. There's a slide presentation that accompanies today's call, and a copy of that presentation is available on the Investors section of our website.

On Slide 4 is our safe harbor statement. Statements made by management on this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities laws. These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results as well as those expressed or implied in any forward-looking statement made here. Please refer to today's press release as well as any other disclosures made by the company regarding the risks to which it is subject, including our 10-K, 10-Q and 8-K reports.

During today's call, management will make reference to non-GAAP financial measures, including organic sales growth, adjusted operating profit, adjusted operating profit margin and adjusted diluted EPS. Reconciliations and limitations of the non-GAAP financial measures to the most comparable financial results prepared in conformity to GAAP are provided in this morning's earnings release.